Deutsche Bank initiates Rhythm Pharmaceuticals at Hold
Deutsche Bank initiated coverage of Rhythm Pharmaceuticals with a Hold rating.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.